Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from Liquid to Solid—A Comprehensive Review of Formulation, Characterization, Applications, and Future Trends
Самоэмульгирующиеся системы доставки лекарственных средств (SEDDS): переход от жидких к твердым формам — всесторонний обзор разработки, характеристики, применения и перспективных направлений
2025-01-05
SCID: 54.1/k7e3akuj
Discuss with AI
Hot-melt extrusionPoorly water-soluble drugsSelf-emulsifying drug delivery systemsSolid SEDDSSupersaturable SEDDS
Figures from the paper
Abstract (AI)
Self-emulsifying drug delivery systems (SEDDS) represent an innovative approach to improving the solubility and bioavailability of poorly water-soluble drugs, addressing significant challenges associated with oral drug delivery. This review highlights the advancements and applications of SEDDS, including their transition from liquid to solid forms, while addressing the formulation strategies, characterization techniques, and future prospects in pharmaceutical sciences. The review systematically analyzes existing studies on SEDDS, focusing on their classification into liquid and solid forms and their preparation methods, including spray drying, hot-melt extrusion, and adsorption onto carriers. Characterization techniques such as droplet size analysis, dissolution studies, and solid-state evaluations are detailed. Additionally, emerging trends, including 3D printing, hybrid systems, and supersaturable SEDDS (Su-SEDDS), are explored. Liquid SEDDS (L-SEDDS) enhance drug solubility and absorption by forming emulsions upon contact with gastrointestinal fluids. However, they suffer from stability and leakage issues. Transitioning to solid SEDDS (S-SEDDS) has resolved these limitations, offering enhanced stability, scalability, and patient compliance. Innovations such as personalized 3D-printed SEDDS, biologics delivery, and targeted systems demonstrate their potential for diverse therapeutic applications. Computational modeling and in silico approaches further accelerate formulation optimization. SEDDS have revolutionized drug delivery by improving bioavailability and enabling precise, patient-centric therapies. While challenges such as scalability and excipient toxicity persist, emerging technologies and multidisciplinary collaborations are paving the way for next-generation SEDDS. Their adaptability and potential for personalized medicine solidify their role as a cornerstone in modern pharmaceutical development.
Key Findings
1
Characterization of SEDDS relies on droplet-size analysis, dissolution testing, and solid-state evaluations to assess formulation performance and properties.
2
Emerging approaches—including 3D printing, hybrid and supersaturable SEDDS, biologics delivery, targeted systems, and computational modeling—support personalized and optimized drug delivery, although scalability and excipient toxicity remain challenges.
3
Liquid SEDDS enhance drug dissolution but are limited by physical stability and leakage problems during handling and storage.
4
SEDDS improve the solubility, gastrointestinal absorption, and bioavailability of poorly water-soluble drugs by forming emulsions in gastrointestinal fluids.
5
Solid SEDDS prepared through spray drying, hot-melt extrusion, or carrier adsorption address liquid-system limitations by improving stability, scalability, and patient compliance.
Research Object
self-emulsifying drug delivery systems (SEDDS), including liquid and solid forms
Research Subject
formulation, characterization, transition from liquid to solid forms, and effects on drug solubility, bioavailability, stability, scalability, and patient compliance
Publication Details
Publication Date
2025-01-05
Journal
Publisher
ISSN
Cited by
96
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest